Filtros de búsqueda

Lista de obras de

5. Tanstuzumab treatment for breast cancer

artículo científico publicado en 2007

A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma

artículo científico publicado en 2017

A case of acute promyelocytic leukemia during gefitinib treatment

scientific article published on 01 October 2006

A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study

artículo científico publicado en 2013

A feasibility study of oxaliplatin (L-OHP) in combination with infusional 5-FU/l-LV (FOLFOX4 regimen) for advanced colorectal cancer

artículo científico publicado en 2008

A lower dose of docetaxel at 60 mg/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer ⬇️

artículo científico publicado el 24 de agosto de 2011

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

artículo científico publicado en 2015

A novel detection strategy for living circulating tumor cells using 5-aminolevulinic acid

artículo científico publicado en 2014

A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line.

artículo científico publicado en 2014

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma

artículo científico publicado en 2016

A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

artículo científico publicado en 2016

A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors ⬇️

artículo científico publicado el 12 de abril de 2011

A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer

artículo científico publicado en 2006

Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling

artículo científico publicado en 2003

An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify

artículo científico publicado en 2005

An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy

artículo científico publicado en 2009

Anal canal carcinoma with Pagetoid spread: report of a case.

artículo científico publicado en 2006

Analysis of the correlation with KRAS gene mutation status and the benefit of cetuximab plus irinotecan as third- line chemotherapy for the Treatment of unresectable metastatic colorectal cancer

artículo científico publicado el 1 de agosto de 2011

Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function ⬇️

artículo científico publicado el 10 de junio de 2011

Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors

artículo científico publicado en 2008

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

artículo científico publicado en 2011

Azacytidine is effective in the therapy related myelodysplastic syndrome

artículo científico publicado en 2017

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

artículo científico publicado en 2017

Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5(+) DLBCL.

artículo científico publicado en 2017

Bevacizumab safety in Japanese patients with colorectal cancer

artículo científico publicado en 2016

Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer ⬇️

artículo científico publicado el 14 de septiembre de 2011

Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.

artículo científico publicado en 2006

Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice

artículo científico publicado en 2007

Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.

artículo científico publicado en 2017

Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization

artículo científico publicado en 2014

Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan

artículo científico publicado el 1 de octubre de 2010

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study

artículo científico publicado en 2019

Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival ⬇️

artículo científico publicado en 2015

Chemotherapy for small-bowel Adenocarcinoma at a single institution

artículo científico publicado en 2009

Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer ⬇️

artículo científico publicado el 18 de diciembre de 2010

Circulating endothelial progenitors and CXCR4‐positive circulating endothelial cells are predictive markers for bevacizumab ⬇️

artículo científico publicado el 24 de febrero de 2011

Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer.

artículo científico publicado en 2013

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

artículo científico publicado en 2011

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer

artículo científico publicado en 2010

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas

artículo científico publicado en 2017

Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib

artículo científico publicado en 2011

Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases: a multi-institutional study

artículo científico publicado en 2010

Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma

artículo científico publicado en 2004

Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma

artículo científico publicado en 2017

Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case

artículo científico publicado en 2010

Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.

artículo científico publicado en 2007

Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

scientific article published on 01 December 2018

Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance

artículo científico publicado en 2017

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients

artículo científico publicado en 2017

Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients

artículo científico publicado en 2017

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

artículo científico publicado en 2011

Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast

artículo científico publicado en 2006

Differentiation of monoblastic cell line UG3 into leukemic dendritic cells.

artículo científico publicado en 2002

Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency

artículo científico publicado en 2010

Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer?

artículo científico publicado en 2007

Does rituximab really induce hepatitis C virus reactivation?

artículo científico publicado en 2008

Efficacy and safety of combined trastuzumab and Paclitaxel therapy as a second-line treatment in women with metastatic breast cancer: a single institutional experience

scientific article published on 01 January 2006

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2016

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

artículo científico publicado en 2018

Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/neu-overexpressing metastatic breast cancer.

artículo científico publicado en 2004

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2007

Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I

artículo científico publicado en 2010

Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

artículo científico publicado en 2008

Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma

artículo científico publicado en 2017

Efficacy of preventive treatment for delayed emesis induced by FOLFOX4 chemotherapy

artículo científico publicado en 2009

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

artículo científico publicado en 2011

Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery

artículo científico publicado en 2010

Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro-platinum(II) treatment

artículo científico publicado en 2005

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

scientific article published on 07 November 2019

Epstein-Barr virus gastric ulcer associated with ruxolitinib

artículo científico publicado en 2016

Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.

artículo científico publicado en 2017

Eradication of breast cancer cells in patients with distant metastasis: the finishing touches? ⬇️

artículo científico publicado el 28 de abril de 2011

Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial

artículo científico publicado en 2012

Familial sideroblastic anemia associated with cardiac atrial septal defect

artículo científico publicado en 2009

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

artículo científico publicado en 2012

Flare-up of dermatomyositis along with recurrence of breast cancer

artículo científico publicado en 2007

Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type

artículo científico publicado en 2016

Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.

artículo científico publicado en 2009

Gastric involvement, a rare site for extramedullary myeloma

artículo científico publicado en 2016

Gene therapy for breast cancer

artículo científico publicado el 1 de abril de 2003

Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital

artículo científico publicado en 2006

Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

artículo científico publicado en 2011

HTLV-I carrier status disclosed at diagnosis of cytomegalovirus gastric ulcer

artículo científico publicado en 2002

Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer

artículo científico publicado en 2010

High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer

artículo científico publicado en 2006

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism

artículo científico publicado en 2012

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone

artículo científico publicado en 2012

How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer? ⬇️

artículo científico publicado el 1 de junio de 2011

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.

artículo científico publicado en 2006

Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma

artículo científico publicado en 2009

Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.

artículo científico publicado en 2015

In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate.

artículo científico publicado en 2010

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)

scientific article published on 15 May 2019

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan

artículo científico publicado en 2017

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane ⬇️

artículo científico publicado el 11 de marzo de 2011

Increased incidence of interstitial pneumonia by CHOP combined with rituximab

artículo científico publicado en 2008

Induction of CPT-11 in a patient on hemodialysis with metastatic rectal cancer

artículo científico publicado en 2005

Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan

artículo científico publicado en 2013

Interleukin-10 differently regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3.

artículo científico publicado en 2002

Intermittent capecitabine monotherapy with lower dose intensity in heavily pretreated patients with metastatic breast cancer.

artículo científico publicado en 2007

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.

artículo científico publicado en 2016

Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens

artículo científico publicado en 2011

Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience

artículo científico publicado en 2008

Is Statin Use Really Associated With Efficacy of Rituximab?

artículo científico publicado en 2010

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib

artículo científico publicado en 2016

Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes

artículo científico publicado en 2005

Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma

artículo científico publicado en 2010

Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells

artículo científico publicado en 2002

Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation

artículo científico publicado en 2010

M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system.

artículo científico publicado en 2006

MEK-ERK is involved in SUMO-1 foci formation on apoptosis

artículo científico publicado en 2007

Management of allergic reactions to oxaliplatin in colorectal cancer patients.

artículo científico publicado en 2008

Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab

artículo científico publicado en 2009

Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan

artículo científico publicado en 2008

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy

artículo científico publicado en 2008

Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

artículo científico publicado en 2018

Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma

artículo científico publicado en 2014

Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

artículo científico publicado en 2017

Myelomatous meningitis: a case report.

artículo científico publicado en 2016

New human myelodysplastic cell line, TER-3: G-CSF specific downregulation of Ca2+/calmodulin-dependent protein kinase IV.

artículo científico publicado en 2002

Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways

artículo científico publicado en 2007

Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy

artículo científico publicado en 2013

Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan

artículo científico publicado en 2017

Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer: a single-center study.

artículo científico publicado en 2004

Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report

artículo científico publicado en 2002

Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients

artículo científico publicado en 2014

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

artículo científico publicado en 2017

Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms.

artículo científico publicado en 2014

Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma

artículo científico publicado en 2016

Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies

artículo científico publicado en 2015

Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphoma

artículo científico publicado en 2012

Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors.

artículo científico publicado en 2011

Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2019

Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy

artículo científico publicado en 2010

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

artículo científico publicado en 2012

Phase I study of ofatumumab, a human anti-CD20 antibody, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

artículo científico publicado en 2013

Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan

scientific article published on 28 March 2019

Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines

artículo científico publicado en 2007

Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma

artículo científico publicado en 2014

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients

artículo científico publicado en 2007

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

artículo científico publicado en 2013

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

artículo científico publicado en 2017

Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes

artículo científico publicado en 2009

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer

artículo científico publicado en 2016

Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer

artículo científico publicado en 2008

Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients ⬇️

artículo científico publicado el 20 de julio de 2011

Preparation of a brochure for patients undergoing FOLFIRI chemotherapy based on survey of adverse reactions

artículo científico publicado en 2008

Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.

artículo científico publicado en 2012

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

artículo científico publicado en 2013

Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan

artículo científico publicado en 2019

Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas ⬇️

artículo científico publicado el 25 de noviembre de 2011

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer ⬇️

artículo científico publicado el 30 de septiembre de 2010

Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3.

artículo científico publicado en 2011

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma

artículo científico publicado en 2012

Radiation therapy for localized duodenal low-grade follicular lymphoma

artículo científico publicado en 2016

Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients

artículo científico publicado en 2014

Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients

artículo científico publicado en 2010

Relative dose intensity of FOLFOX4 regimen

artículo científico publicado en 2008

Retrospective analysis of FOLFOX4 neurotoxicity for recovery from advanced colorectal cancer

artículo científico publicado en 2008

Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.

artículo científico publicado en 2007

Risk management in ambulatory anti-cancer therapy, focusing on nausea and vomiting

artículo científico publicado el 1 de noviembre de 2011

Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma

artículo científico publicado en 2007

Rituximab resistance in B-cell lymphoma and its elimination

artículo científico publicado en 2009

Role of bone marrow-derived monocytes/macrophages in the repair of mucosal damage caused by irradiation and/or anticancer drugs in colitis model

artículo científico publicado en 2010

Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study.

artículo científico publicado en 2017

Safety and efficacy analysis of FOLFOX4 regimen in elderly compared to younger colorectal cancer patients

artículo científico publicado en 2008

Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study

artículo científico publicado en 2020

Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study

artículo científico publicado en 2012

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study

scientific article published on 01 August 2018

Severe infusion reaction induced by trastuzumab: A case report ⬇️

artículo científico publicado el 1 de enero de 2003

Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report

artículo científico publicado el 1 de octubre de 2003

Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection

artículo científico publicado el 1 de noviembre de 2010

TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis.

artículo científico publicado en 2018

The clonal evolution during long-term clinical course of multiple myeloma

scientific article published on 30 August 2020

The incidence of gastrointestinal bleeding, thromboembolic events, and gastrointestinal perforation in metastatic or unresectable gastric cancer during chemotherapy

artículo científico publicado el 1 de noviembre de 2010

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan

artículo científico publicado en 2008

Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis ⬇️

artículo científico publicado el 3 de marzo de 2011

Trigeminal neuralgia caused by lymphomatous compression at oval foramen

artículo científico publicado en 2002

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer

artículo científico publicado en 2011

[A case of mediastinal cancer of unknown primary with elevation of serum concentrations of interleukin-6].

artículo científico publicado en 2008

[A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer]

artículo científico publicado en 2006

[Administration-limiting factor of bevacizumab for patient with metastatic colorectal cancer]

artículo científico publicado en 2011

[Breast cancer and Her-2]

artículo científico publicado en 2007

[Lung injury associated with bortezomib therapy in Japan]

scientific article published on 01 December 2011

[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer]

artículo científico publicado en 2011

[Proteasome inhibitors]

artículo científico publicado en 2004

[Recent progress in rituximab therapy and its resistance--how do we overcome?]

artículo científico publicado en 2007

[Resistance to rituximab and CD20 mutation]

scientific article published on 01 January 2007

[Rituximab and hematological malignancy]

artículo científico publicado en 2004

[Treatment of breast cancer by using trastuzumab, a molecular targeted therapeutic agent]

scientific article published on 01 September 2005

[Tumor lysis syndrome]

scientific article published on 01 December 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda